Skip to content

The Randomized Controlled Study of Zhu Lian Acupuncture and Moxibustion for Treating Respiratory Function Impairment in the Post-Stroke Recovery Phase

The Randomized Controlled Study of Zhu Lian Acupuncture and Moxibustion for Treating Respiratory Function Impairment in the Post-Stroke Recovery Phase

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078908
Enrollment
Unknown
Registered
2023-12-20
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction

Interventions

Acupuncture group:Zhu Lian Excitation Type II technique treatment
Control group:Using the upper and lower limb cross-training device

Sponsors

Seventh People's Hospital of Nanning
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with cerebral infarction for a duration exceeding 2 weeks but within 6 months. 2. NIHSS (National Institutes of Health Stroke Scale) score <16. 3. Aged between 30 and 70 years. 4. Pulmonary function testing indicating the presence of ventilation impairment. 5. No history of chronic respiratory diseases. 6. No facial nerve paralysis. 7. No sensory aphasia.

Exclusion criteria

Exclusion criteria: 1. Patients unable to cooperate with pulmonary function tests. 2. Patients with untreated pulmonary infections. 3. Patients with a history of asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, or interstitial lung disease. 4. Patients with unstable vital signs or severe organ dysfunction in the heart, liver, kidneys, or other organs. 5. Patients with impaired comprehension and an inability to comply with treatment. 6. Patients with severe skin allergies. 7. Patients with alcohol or substance dependence. 8. Patients with severe physical illnesses or mental disorders. 9. Patients with a history of epilepsy. 10. Participants who have recently taken part in similar studies.

Design outcomes

Primary

MeasureTime frame
6-minute walk test and Borg scale scores;forced vital capacity, FVC;forced expiratory volume in one second, FEVl;peak expiratory flow, PEF;

Secondary

MeasureTime frame
PaO2;PaCO2;

Countries

China

Contacts

Public ContactHongying.Li

Seventh People's Hospital of Nanning

13223269@qq.com+86 139 7712 5331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026